Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

2

Revenue 2017

Revlimid

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Revlimid was produced by Celgene.

NICE set to knock-back Amgen's myeloma treatment Kyprolis

NICE set to knock-back Amgen's myeloma treatment Kyprolis NICE's draft guidance is part of its assessment for NHS use of Kyprolis (carflizomib) in combination with Celgene's Revlimid (lenalidomide) and dexamethasone to treat adults who have received at ... NICE's draft guidance on its use in combination with

Celgene bolsters blood cancer portfolio with $600m EngMab buy

Celgene bolsters blood cancer portfolio with $600m EngMab buy bb2121 started phase I testing earlier this year. EngMab consolidates Celgene's position as the top company in the multiple myeloma market at the moment, thanks to blockbuster drugs Revlimid (lenalidomide)

Celgene disappointed as Revlimid fails lymphoma trial

Celgene disappointed as Revlimid fails lymphoma trial PFS alone is not considered compelling as Revlimid carries a risk of serious side effects, including thrombosis. ... It is important to note that Celgene is not abandoning Revlimid as a DLBCL therapy just yet.

Celgene’s Revlimid cleared for aggressive lymphoma type in EU

Celgene’s Revlimid cleared for aggressive lymphoma type in EU The European Commission has approved Celgene's Revlimid for a new indication that for the first time expands the drug's use beyond multiple myeloma in the EU. ... The new labeling means that Revlimid (lenalidomide) can now be used to treat adults with

Amgen's Kyprolis wins new indication in Europe

Amgen's Kyprolis wins new indication in Europe Last November it was approved in Europe in combination with Celgene's Revlimid (lenalidomide) as well as dexamethasone in this therapy area, after receiving the green light in the US more

[ Previous 5 results ] 7 8 9 10 11 12 13 14 15 16 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Accession

Accession was a born from a passion and a vision. A passion to harness the power of market access to...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics